National Research (NASDAQ:NRC) Shares Gap Up to $34.36

National Research Co. (NASDAQ:NRC) gapped up prior to trading on Wednesday . The stock had previously closed at $34.36, but opened at $35.84. National Research shares last traded at $34.37, with a volume of 2,135 shares changing hands.

Analysts Set New Price Targets

Separately, TheStreet downgraded National Research from a “b-” rating to a “c+” rating in a report on Thursday, January 11th.

National Research Stock Down 1.4 %

The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.67 and a current ratio of 0.67. The firm has a market capitalization of $783.95 million, a P/E ratio of 26.30 and a beta of 0.42. The stock has a fifty day moving average price of $38.66 and a two-hundred day moving average price of $40.20.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, February 13th. The company reported $0.36 EPS for the quarter. The firm had revenue of $38.00 million during the quarter. National Research had a return on equity of 47.79% and a net margin of 20.84%.

National Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were paid a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a yield of 1.46%. National Research’s payout ratio is currently 38.40%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. iA Global Asset Management Inc. bought a new position in National Research during the 3rd quarter worth $11,124,000. Charles Schwab Investment Management Inc. grew its stake in National Research by 4.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 111,434 shares of the company’s stock worth $4,944,000 after buying an additional 4,895 shares during the last quarter. Swiss National Bank grew its stake in National Research by 1.6% during the 3rd quarter. Swiss National Bank now owns 32,500 shares of the company’s stock worth $1,442,000 after buying an additional 500 shares during the last quarter. Comerica Bank acquired a new position in National Research during the 3rd quarter worth $6,939,000. Finally, Conestoga Capital Advisors LLC boosted its position in National Research by 1.0% during the 4th quarter. Conestoga Capital Advisors LLC now owns 780,806 shares of the company’s stock worth $30,889,000 after acquiring an additional 7,591 shares during the period. 47.26% of the stock is currently owned by institutional investors.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.